Drug Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

Drug Name YH32367
Trade Name
Synonyms YH 32367|YH-32367|ABL105|AB L105|AB-L105
Drug Descriptions

YH32367 (ABL105) is a bispectific antibody targeting ERBB2 (HER2) and TNFRSF9 (4-1BB), which potentially enhances antitumor immune response and inhibits tumor growth (Cancer Res 2022;82(12_Suppl):Abstract nr 1139).

DrugClasses HER2 (ERBB2) Antibody 76 TNFRSF9 Antibody 32
CAS Registry Number NA
NCIT ID NA

Filtering

  • Case insensitive filtering will display rows if any text in any cell matches the filter term
  • Use simple literal full or partial string matches
  • Separate multiple filter terms with a space. Any order may be used (i. e. a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page. Filtering has no impact on query parameters.
  • Use quotes to match on a longer phrase with spaces (i.e. "mtor c1483f")

Sorting

  • Generally, the default sort order for tables is set to be first column ascending; however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column. Be sure to set ascending or descending order for a given column before moving on to the next column.

Therapy Name Drugs Efficacy Evidence Clinical Trials
YH32367 YH32367 0 1


Additional content available in CKB BOOST